ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q2SCImago #4,765Hybrid

Journal of the Renin-Angiotensin-Aldosterone System

Abbreviation (ISO):J RENIN-ANGIO-ALDO S
•
Identifier (ISSN):1470-3203(Print)/1752-8976(Online)
•
Publisher:SAGE Publications Ltd
Clarivate IF (2026)
10.6↑ +6.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of the Renin-Angiotensin-Aldosterone System

WoS Q1
059141.220181.3620191.4220201.6420214.1120222.920232.120244.1202510.62026
Annual Impact Factor Metric
Current (2026):10.6
Scopus SJR & RankScopus Q2
1.02
#4,765

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
54

54 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate4.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
18articles/year
46.15% Gold OA•52.63% Original Research

Aims & Scope

JRAAS is a peer-reviewed, open access journal, serving as a resource for biomedical professionals, primarily with an active interest in the renin-angiotensin-aldosterone system in humans and other mammals. It publishes original research and reviews on the normal and abnormal function of this system and its pharmacology and therapeutics, mostly in a cardiovascular context but including research in all areas where this system is present, including the brain, lungs and gastro-intestinal tract.

Topics Covered (Recognized by AI)
Medicine97.2%Biology96.2%Internal medicine96.2%Endocrinology90.8%Radiology82.8%Blood pressure82.3%Genetics82.2%Chemistry80.9%Biochemistry77.4%Renin–angiotensin system54.6%Receptor50.9%Pathology42.2%Angiotensin II41%Cardiology37.7%Angiotensin-converting enzyme27.5%Gene25.5%Psychology22.7%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PERIPHERAL VASCULAR DISEASE

Q1
Rank6/100
IndexSCIE
JCISCIE2026

PERIPHERAL VASCULAR DISEASE

Q1
Rank17/100
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF10.6
Articles / Year37
Total Citations8
2025
IF4.1
Articles / Year41
Total Citations78
2024
IF2.1
Articles / Year7
Total Citations56
2023
IF2.9
Articles / Year14
Total Citations322
2022
IF4.109
Articles / Year20
Total Citations387

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,765Scopus Q2SCImago Profile
Scopus Coverage:2000-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
1.02

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
6.86

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,110 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations230
3-Year Documents40
Citable Documents40

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EndocrinologyQ2
Internal MedicineQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区PERIPHERAL VASCULAR DISEASE
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of the Renin-Angiotensin-Aldosterone System (abbr: J RENIN-ANGIO-ALDO S, ISSN: 1470-3203) is a peer-reviewed international scholarly journal in the field of Medicine, published by SAGE Publications Ltd in England since 2000. The periodical holds a Journal Impact Factor (JIF) of 10.6, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.020 (Q2), an H-index of 54.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 18 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,110 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
SAGE Publications Ltd
Publication Language
English
Frequency
Quarterly
Founding Year
2000
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
SAGE PUBLICATIONS LTD, 1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 726ab907-41ee-4926-b15c-048d63534a88
Database Updated: 2026-10-01